Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining Questions

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Medifocus, Inc. is pleased to announce that it has filed on January 22, 2010, its response to two (2) remaining questions with the FDA in the United States of America (USA) to obtain clearance to initiate a pivotal phase III clinical trial using the Company's Microfocus APA 1000 System for the treatment of breast cancer in the USA and worldwide.

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.